Related Experiment Video
Updated: May 6, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
9.6K
Management of recurrent retroperitoneal sarcoma
David E Gyorki1, Murray F Brennan
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Journal of Surgical Oncology
|October 25, 2013
Summary
Retroperitoneal sarcomas often recur due to their hidden location. Resectability of recurrent disease is key for patient outcomes, highlighting the need to understand tumor biology for effective management.
Area of Science:
- Oncology
- Surgical Oncology
- Pathology
Background:
- Retroperitoneal sarcomas constitute approximately 15% of all soft tissue sarcomas.
- Their concealed location and complex anatomy lead to high rates of local recurrence.
- Factors influencing recurrence include tumor subtype, resection completeness, and hospital case volume.
Purpose of the Study:
- To analyze predictors of local recurrence in retroperitoneal sarcomas.
- To identify the most critical factor influencing outcomes after recurrence.
- To emphasize the role of tumor biology in managing recurrent retroperitoneal sarcoma.
Main Methods:
- Review of patient data for retroperitoneal sarcoma cases.
- Analysis of recurrence rates based on histological subtype, resection margins, and hospital volume.
- Evaluation of prognostic factors for patients with recurrent disease.
Main Results:
- Local recurrence is common in retroperitoneal sarcomas.
- Histological subtype, completeness of resection, and hospital case volume are predictors of recurrence.
- The resectability of recurrent tumor is the most significant predictor of patient outcome.
Conclusions:
- Effective management of recurrent retroperitoneal sarcoma requires understanding tumor biology.
- Surgical resectability is paramount for improving outcomes in recurrent cases.
- Multidisciplinary approaches are essential for optimizing treatment strategies.
